Teresa Mc Carthy Avidity Biosciences, Inc. (RNA) insider trading activity

RNA Quotes by TradingView

Teresa Mc Carthy is Chief Human Resources Officer of Avidity Biosciences, Inc.. Currently has a direct ownership of 97,130 shares of RNA, which is worth approximately $4.29 Million. The most recent transaction as insider was on Sep 15, 2025, when has been sold 15,000 shares (Common Stock) at a price of $41.41 per share, resulting in proceeds of $621,150. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97.1K
0% 3M change
40.73% 12M change
Total Value Held $4.29 Million

Teresa McCarthy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 15 2025
SELL
Open market or private sale
$621,150 $41.41 p/Share
15,000 Reduced 13.38%
97,130 Common Stock
Sep 15 2025
BUY
Exercise of conversion of derivative security
$335,100 $22.34 p/Share
15,000 Added 11.8%
112,130 Common Stock
Aug 15 2025
SELL
Open market or private sale
$465,600 $46.56 p/Share
10,000 Reduced 9.33%
97,130 Common Stock
Aug 15 2025
BUY
Exercise of conversion of derivative security
$223,400 $22.34 p/Share
10,000 Added 8.54%
107,130 Common Stock
Mar 20 2025
SELL
Open market or private sale
$241,584 $31.06 p/Share
7,778 Reduced 7.41%
97,130 Common Stock
Jan 21 2025
SELL
Open market or private sale
$84,627 $28.6 p/Share
2,959 Reduced 2.74%
104,908 Common Stock
Jan 06 2025
BUY
Grant, award, or other acquisition
-
25,000 Added 18.82%
107,867 Common Stock
Dec 18 2024
SELL
Open market or private sale
$364,191 $32.66 p/Share
11,151 Reduced 11.86%
82,867 Common Stock
Dec 16 2024
SELL
Open market or private sale
$831,500 $33.26 p/Share
25,000 Reduced 21.01%
94,018 Common Stock
Dec 16 2024
BUY
Exercise of conversion of derivative security
$355,500 $14.22 p/Share
25,000 Added 17.36%
119,018 Common Stock
Nov 18 2024
SELL
Open market or private sale
$1,028,500 $41.14 p/Share
25,000 Reduced 21.01%
94,018 Common Stock
Nov 18 2024
BUY
Exercise of conversion of derivative security
$355,500 $14.22 p/Share
25,000 Added 17.36%
119,018 Common Stock
Oct 16 2024
SELL
Open market or private sale
$1,213,000 $48.52 p/Share
25,000 Reduced 21.01%
94,018 Common Stock
Oct 16 2024
BUY
Exercise of conversion of derivative security
$355,500 $14.22 p/Share
25,000 Added 17.36%
119,018 Common Stock
Sep 23 2024
SELL
Open market or private sale
$578,732 $44.0 p/Share
13,153 Reduced 16.01%
69,018 Common Stock
Sep 19 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 34.72%
94,018 Common Stock
Sep 11 2024
SELL
Open market or private sale
$1,010,000 $40.4 p/Share
25,000 Reduced 30.42%
57,171 Common Stock
Sep 11 2024
BUY
Exercise of conversion of derivative security
$355,500 $14.22 p/Share
25,000 Added 23.33%
82,171 Common Stock
Jun 18 2024
SELL
Open market or private sale
$385,978 $39.13 p/Share
9,864 Reduced 23.47%
32,171 Common Stock
Jun 17 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 46.65%
57,171 Common Stock
Jan 22 2024
SELL
Open market or private sale
$20,918 $10.13 p/Share
2,065 Reduced 10.81%
17,035 Common Stock
Jan 20 2024
BUY
Grant, award, or other acquisition
-
16,500 Added 48.59%
17,458 Common Stock
Jan 20 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 48.83%
20,958 Common Stock
TM

Teresa Mc Carthy

Chief Human Resources Officer
San Diego, CA

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

News

Receive news related to Avidity Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RNA